Hinge Health director granted 9,896 RSUs

Sloat Tyler reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Sloat Tyler reported acquisition or exercise transactions in this Form 4 filing.

Hinge Health, Inc. director Tyler Sloat received an award of 9,896 shares of Class A Common Stock as a grant, reported at a price of $0.00 per share. After this transaction, he directly holds 9,896 shares.

The filing explains that these 9,896 shares are restricted stock units (RSUs), which vest in accordance with the terms of the award. Each RSU represents a contingent right to receive one share of Class A Common Stock, so the actual share delivery depends on future vesting conditions.

Insider Trade Summary

Grant/Award: 9,896 shares

Grant/Award 1 txn

Insider Sloat Tyler

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	9,896	$0.00	$0.00

Holdings After Transaction: Class A Common Stock — 9,896 shares (Direct)

Footnotes (1)

1. F1. Includes 9,896 restricted stock units that vest in accordance with the terms of the award. Each RSU represents a contingent right to receive one share of Class A Common Stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Hinge Health (HNGE) report for Tyler Sloat?

Hinge Health reported that director Tyler Sloat acquired 9,896 shares of Class A Common Stock through a grant. The transaction was coded as an award, not a market purchase, and carried a reported price of $0.00 per share.

How many Hinge Health (HNGE) shares does Tyler Sloat hold after this Form 4?

Following the reported grant, Tyler Sloat directly holds 9,896 shares of Hinge Health Class A Common Stock. The entire position comes from this single award and is structured as restricted stock units subject to vesting conditions over time.

What type of equity did Hinge Health (HNGE) grant to Tyler Sloat?

Hinge Health granted 9,896 restricted stock units (RSUs) to director Tyler Sloat. The footnote states each RSU represents a contingent right to receive one share of Class A Common Stock, vesting according to the terms of the award agreement.

Was cash paid for the 9,896 HNGE shares reported in the Form 4?

No cash changed hands in the reported transaction; the grant price is listed as $0.00 per share. This indicates a compensatory equity award rather than an open-market purchase, with value realized as the restricted stock units vest.

Are the 9,896 Hinge Health (HNGE) RSUs immediately available as common shares?

The 9,896 RSUs are not immediately delivered as common shares. According to the footnote, each unit is a contingent right that converts into one Class A share only as it vests under the specific terms of the award.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 05:18 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sloat Tyler

(Last) (First) (Middle)

C/O HINGE HEALTH, INC.

455 MARKET STREET, SUITE 700

(Street)

SAN FRANCISCO CALIFORNIA 94105

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hinge Health, Inc. [ HNGE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	03/16/2026		A		9,896	A	$0	9,896(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 9,896 restricted stock units that vest in accordance with the terms of the award. Each RSU represents a contingent right to receive one share of Class A Common Stock.

	/s/ James Budge, Attorney-in-Fact	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)